Paediatric Ketone Measurement and Intervention in Non-Diabetic Patients in Australasian Emergency Departments: A

Shannon E Trenwith1, Robert Millar2,3, Simon S Craig4,5,6

  • 1Emergency Department, The Royal Children's Hospital, Melbourne, Victoria, Australia.

Insights

Nurses and doctors in Australian and New Zealand emergency departments frequently screen non-diabetic children for elevated ketone levels. However, there are significant variations in how these levels are interpreted and managed.

Area of Science:

  • Pediatric Emergency Medicine
  • Clinical Practice Variation
  • Biochemical Monitoring

Background:

  • Elevated ketone levels in non-diabetic children presenting to emergency departments (EDs) require careful assessment.
  • Current practices for screening, monitoring, and treating these children vary significantly across healthcare providers.

Purpose of the Study:

  • To evaluate the current self-reported practices regarding screening, monitoring, and treatment of elevated ketone levels in non-diabetic children.
  • To identify future research priorities in this clinical area.

Main Methods:

  • A voluntary electronic survey was distributed to healthcare professionals within the Paediatric Research in Emergency Departments International Collaborative (PREDICT) network.
  • Respondents provided data on their self-reported practices, beliefs, and research priorities concerning elevated ketone levels.

Main Results:

  • Responses were received from 423 nurses and 397 doctors across 28 Australian and New Zealand sites.
  • Nurses were more likely to screen (90%) and monitor (66%) ketone levels compared to doctors (75% and 37%, respectively).
  • Definitions of 'elevated' and 'severely elevated' ketone levels varied considerably between nurses and doctors, impacting management decisions, including fluid administration strategies.

Conclusions:

  • Healthcare professionals in Australian and New Zealand EDs routinely screen non-diabetic children for elevated ketone levels.
  • Significant discrepancies exist in the interpretation and management of elevated ketone levels, highlighting a need for standardized protocols and further research.
Abstract

Related Concept Videos

Diagnosing Acidosis and Alkalosis01:24

Diagnosing Acidosis and Alkalosis

Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2  and...
978
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
5.6K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
171
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
234
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
191